An Assessment of Statin Safety by Nephrologists
- 17 April 2006
- journal article
- practice guideline
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (8) , S82-S85
- https://doi.org/10.1016/j.amjcard.2005.12.015
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- Statin Safety: Lessons from New Drug Applications for Marketed StatinsThe American Journal of Cardiology, 2006
- Renal tubular toxicity of HMG-CoA reductase inhibitorsNephrology Dialysis Transplantation, 2004
- Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney CellsJournal of the American Society of Nephrology, 2004
- Inhibitors of HMG-CoA Reductase Reduce Receptor-mediated Endocytosis in Human Kidney Proximal Tubular CellsJournal of the American Society of Nephrology, 2004
- Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomesBritish Journal of Clinical Pharmacology, 2004
- Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuriaClinical Nephrology, 2003
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAmerican Journal of Kidney Diseases, 2003
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Proteinuria as complication of simvastatin treatmentThe Lancet, 1990